COMP <GO>
IRTC vs JNJ // ALTMAN Z-SCORE & DEBT/EQUITY
iRhythm Holdings Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: IRTC 4
— JNJ 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: JNJ
LAST: $123.37 (-3.47%) • MKT CAP: $4.21B
balance-sheet
3.01
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRTC VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRTC | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 70.60% | 67.90% | +2.70 | IRTC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.50% | 25.50% | -39.00 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.82% | 2.97% | -2.15 | JNJ | /fcf-yield <GO> |
| Operating Margin | -7.70% | 34.70% | -42.40 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -6.00% | 28.50% | -34.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 26.20% | 6.00% | +20.20 | IRTC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 3.01 | 5.59 | -2.58 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.80% | 7.20% | -0.40 | IRTC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.2 | 60.4 | +2.83 | IRTC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 1.08 | -0.10 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 30.0x | 23.0x | +7.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.21B | $662.49B | -$658.28B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRTC REV | JNJ REV | IRTC GROSS % | JNJ GROSS % | IRTC FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $747.1M | $94.19B | 70.6% | 67.9% | $34.5M | $19.70B |
| FY 2024 | $591.8M | $88.82B | 68.9% | 69.1% | -$30.6M | $19.84B |
| FY 2023 | $492.7M | $85.16B | 44.0% | 44.0% | -$72.3M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRTC // BETA 0.98
JNJ // BETA 1.08